Today: 21 May 2026
Browse Category

UK Stocks 10 January 2026 - 3 March 2026

Compass Group PLC stock slips in London as CPG investors eye April dollar switch

Compass Group PLC stock slips in London as CPG investors eye April dollar switch

Compass Group shares fell 0.98% to 2,231 pence in early London trading Tuesday, continuing weakness since a February selloff tied to AI concerns at office clients. The company will switch its London-listed share trading currency from sterling to dollars on April 1. Compass reported 1.7 billion total voting rights as of Feb. 28 and forecasts 7.2% organic revenue growth for fiscal 2026. No fresh results are due this week.
3 March 2026
··
UK stocks Monday: Iran strikes jolt oil, Barclays credit scare lingers, earnings stack up

UK stocks Monday: Iran strikes jolt oil, Barclays credit scare lingers, earnings stack up

Oil and shipping risks after U.S.-Israeli strikes on Iran are expected to drive London’s market open Monday, following OPEC+’s tentative deal to raise output as Gulf shipments stalled. The FTSE 100 closed Friday at a record 10,910.55, up 0.6%, with Barclays down 4.2% and IAG off 7.5%. At least 150 tankers anchored outside Hormuz on Sunday after Iranian warnings. UK factory PMI data is due at 09:30 GMT.
1 March 2026
···
Rolls-Royce share price ticks up as RR.L steadies after big buyback, outlook lift

Rolls-Royce share price ticks up as RR.L steadies after big buyback, outlook lift

Rolls-Royce shares rose 0.5% to 1,359 pence in early London trading Friday, after a 9.1% surge Thursday that helped lift the FTSE 100 to a record close. The company reported £3.46 billion in 2025 operating profit and launched a share buyback of up to £2.3 billion, set to run through December 23. Rolls-Royce forecasts £4.0–£4.2 billion profit and £3.6–£3.8 billion free cash flow in 2026.
27 February 2026
··
FTSE Near Record Highs: A Beginner’s Guide to Investing in UK Stocks, ISAs and ETFs

FTSE Near Record Highs: A Beginner’s Guide to Investing in UK Stocks, ISAs and ETFs

London’s FTSE 100 rose 0.2% to 10,506.04 by late morning Tuesday, nearing a record high as traders increased bets on a Bank of England rate cut next month. The FTSE 250 slipped 0.1%, with Plus500 shares falling after an executive share sale. Investors awaited January inflation data due Wednesday. A Reuters poll found most economists expect a 0.25-point rate cut in March.
17 February 2026
··
Rolls-Royce share price today: RR.L dips early after Monday rally as results loom

Rolls-Royce share price today: RR.L dips early after Monday rally as results loom

Rolls-Royce shares slipped 0.1% to 1,296.5 pence in early London trading Tuesday after a 2.1% gain Monday. Bernstein maintained a “Market-Perform” rating and a 900p target, citing strong aftermarket demand. Investors await full-year results on Feb. 26 and updates on the £200 million buyback due to end Feb. 24. Trading volume Monday was 5.7 million shares, well below the 50-day average.
17 February 2026
··
Sage Group plc stock: shares rebound after two-day selloff, but the 52-week low is still in play

Sage Group plc stock: shares rebound after two-day selloff, but the 52-week low is still in play

Sage Group shares rose 0.5% to 797.6 pence in early London trading Friday after two sessions of steep declines pushed the stock to a 52-week low. Volume reached about 378,000 shares by 0929 GMT. The stock remains down 6% for the week and trades about 40% below its 52-week high. Investors await Sage’s interim results on May 21 for updates on demand and margins.
13 February 2026
··
Experian share price slides again as EXPN extends selloff in London

Experian share price slides again as EXPN extends selloff in London

Experian shares fell 1.3% to 2,749 pence in early London trading Wednesday, extending a four-day losing streak. The stock has dropped nearly 10% this week amid investor concerns over AI disruption, regulatory uncertainty, and Fair Isaac’s move to sell mortgage credit scores directly to lenders. Investors are watching for central bank signals and Experian’s February dividend.
28 January 2026
···
Babcock share price today: BAB.L slips despite fresh buybacks and higher broker targets

Babcock share price today: BAB.L slips despite fresh buybacks and higher broker targets

Babcock shares slipped 0.34% to 1,449p in early London trading after announcing further share buybacks. Jefferies and JPMorgan raised their target prices to 1,670p and 1,700p, respectively, as investors watch for a June board handover. The company reaffirmed its FY26 outlook and margin target, citing contracted revenue and new Arrowhead licence deals in Indonesia.
27 January 2026
··
Aviva share price rebounds in early London trade after Friday’s slide — what’s next for AV.L

Aviva share price rebounds in early London trade after Friday’s slide — what’s next for AV.L

Aviva shares rose 1.8% to 630.4 pence in early London trading Monday, partially rebounding from Friday’s 5.17% drop. The stock remains about 11.6% below its Jan. 6 high after heavy trading late last week. Investors are watching for March 5 results and updates on the Direct Line integration. Aviva will launch unlimited 24/7 digital GP appointments for policyholders starting Jan. 29.
26 January 2026
··
3i Group share price heads into new week near 3,289p — here’s what matters before Thursday’s update (LSE:III)

3i Group share price heads into new week near 3,289p — here’s what matters before Thursday’s update (LSE:III)

3i Group shares closed Friday at 3,289p, up 0.49%, but remain well below last year’s high. The stock trades about 15% above net asset value as investors await the Q3 update on Jan. 29. Focus is on Action, 3i’s largest holding, after it reported 17% sales growth in the last half-year. Monday’s trading will test whether the NAV premium holds.
25 January 2026
···
Ocado share price slides about 7% as Trump tariff threat drags UK mid-caps

Ocado share price slides about 7% as Trump tariff threat drags UK mid-caps

Ocado Group shares fell 7% to 262 pence in London trading Monday, nearing session lows as volume hit 1.4 million. The drop followed U.S. President Trump’s tariff threats against Britain and other European countries, which sent the FTSE 250 down 0.9%. A regulatory filing Friday showed Ocado executives bought shares via an employee plan. Investors await Ocado’s FY25 results on Feb. 26, with focus on cash flow.
19 January 2026
··
1 2 3

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop